---
title: "Wells Fargo initiates coverage on LeMaitre Vascular with 'equal weight' rating"
date: "2025-02-14 00:49:05"
summary: "** Brokerage Wells Fargo initiates coverage on medtech firm LeMaitre Vascular with an \"equal weight\" rating and a PT of $95 ** Brokerage says LMAT could be poised for growth in 2025 if it pursues strategic mergers and acquisitions; adds that the company has $300 million available for deals that..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Brokerage Wells Fargo initiates coverage on medtech firm LeMaitre Vascular with an "equal weight" rating and a PT of $95

\*\* Brokerage says LMAT could be poised for growth in 2025 if it pursues strategic mergers and acquisitions; adds that the company has $300 million available for deals that could bolster its device portfolio

\*\* Wells Fargo observes LMAT may acquire companies that make surgical sealants, devices that block blood flow and clips for tying off blood vessels

\*\* "We believe that the stock fully prices in an optimistic outlook for pricing and volume growth in 2025 and beyond" - brokerage

\*\* Stock up about 55% in the last 12 months

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P41PQ:0-wells-fargo-initiates-coverage-on-lemaitre-vascular-with-equal-weight-rating/)
